Effects of epidermal growth factor and mitogenic blockers on rat colonic tumour growth in vivo
Related Experiment Video
Updated: Jun 2, 2026

A Simple Device to Rapidly Prepare Whole Mounts of the Mouse Intestine
Published on: October 27, 2015
1UNIV WESTERN AUSTRALIA,QUEEN ELIZABETH II MED CTR,DEPT SURG,NEDLANDS,WA 6009,AUSTRALIA.
Abstract:
A protocol for tumour cell inoculation (Per192NR and Per237 rat colon cancer cells) and implantation of mini-osmotic pumps in inbred rats was established. Surgical procedures and tumour growth did not affect red and white blood cell counts. Per237 did not grow in these rats while Per192NR formed poorly differentiated carcinomas which were not affected by EGF intraperitoneal (IP) or intravenous (IV), oleic acid (IP) or verapamil (IP or oral) administration. Haematological parameters and rat growth rates were not affected by EGF (IP and IV), verapamil (IP) and oleic acid (IP) treatment. This protocol provides a method for studying the effect of various cancer drugs in vivo.
More Related Videos
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
07:05Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
Published on: May 12, 2019